Phibro Animal Health Corporation revised earnings guidance for the fiscal year ending June 30, 2023. For the period, the company expects net sales to be in the range of $960 million and $1 billion, net income to be in the range of $39 million and $43 million, from $45 million and $49 million and Diluted EPS to be in the range of $0.96 and $1.06, from $1.11 and $1.21.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.64 USD | +1.65% | -6.09% | +7.86% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.86% | 504M | |
-20.14% | 70.08B | |
-10.97% | 6.43B | |
+18.88% | 3.52B | |
-3.13% | 3.11B | |
-1.52% | 1.38B | |
-15.41% | 1.37B | |
-3.32% | 1.24B | |
-13.54% | 1.13B | |
-2.99% | 1.02B |
- Stock Market
- Equities
- PAHC Stock
- News Phibro Animal Health Corporation
- Phibro Animal Health Corporation Revises Earnings Guidance for the Fiscal Year Ending June 30, 2023